Wim Van Hul - Genetic Mutations

Author Information

Wim Van Hul is a distinguished researcher affiliated with the Department of Medical Genetics at the University of Antwerp and Antwerp University Hospital in Antwerp, Belgium. His work primarily revolves around bone biology and genetic disorders related to bone mass and structure.

Research Contributions

Wim Van Hul has made significant contributions to the field of bone biology, particularly in understanding rare bone diseases and genetic variations affecting bone mass and structure. His recent work includes studies on innovative models in bone biology, loss-of-function variants in extreme tall stature, and the management of Camurati-Engelmann Disease. He has also contributed to research on the genetic underpinnings of Paget's disease of bone and obesity-associated fatty liver disease, demonstrating his broad expertise in skeletal genetic diseases.

Aliases

Wim Van Hul is also known by the following aliases: W Van Hul, W. Van Hul, and W. Van Hul.

Publication and Citation Metrics

Metric	Value
Total Citations	9507
h-index	48
Paper Count	189

Publications:

Editorial: Innovative Models in Bone Biology: What can be Learned From Rare Bone Diseases?

DOI: 10.3389/fendo.2022.892799

Year: 2022

Broadening the Spectrum of Loss-of-Function Variants in NPR-C-Related Extreme Tall Stature

DOI: 10.1210/jendso/bvac019

Year: 2022

Camurati-Engelmann Disease Complicated by Hypopituitarism: Management Challenges and Literature Review of Outcomes With Bisphosphonates

DOI: 10.1016/j.aace.2021.10.002

Year: 2022

Identification of Compound Heterozygous Variants in LRP4 Demonstrates That a Pathogenic Variant outside the Third β-Propeller Domain Can Cause Sclerosteosis

DOI: 10.3390/genes13010080

Year: 2021

Perspective of the GEMSTONE Consortium on Current and Future Approaches to Functional Validation for Skeletal Genetic Disease Using Cellular, Molecular and Animal-Modeling Techniques

DOI: 10.3389/fendo.2021.731217

Year: 2021

A Panel-Based Sequencing Analysis of Patients with Paget's Disease of Bone Suggests Enrichment of Rare Genetic Variation in regulators of NF-κB Signaling and Supports the Importance of the 7q33 Locus.

DOI: 10.1007/s00223-021-00881-w

Year: 2021

A Roadmap to Gene Discoveries and Novel Therapies in Monogenic Low and High Bone Mass Disorders

DOI: 10.3389/fendo.2021.709711

Year: 2021

A targeted multi-omics approach reveals paraoxonase-1 as a determinant of obesity-associated fatty liver disease

DOI: 10.1186/s13148-021-01142-1

Year: 2021

Functional assessment of coding and regulatory variants from the DKK1 locus

DOI: 10.1016/j.bonr.2020.100348

Year: 2020

Functional Assessment of Coding and Regulatory Variants From the DKK1 Locus

DOI: 10.1002/jbm4.10423

Year: 2020

How Are Genetic Diseases Diagnosed?

How is PCR Used to Detect Genetic Mutations?

What Tools are Used for Data Analysis?

How Does Biotechnology Impact Environmental Conservation?

What is Sickle Cell Anemia?

What are the Technical Challenges?

How is Karyotyping Performed?

Is Autism Spectrum Disorder Genetic?

Why are Non-Coding Regions Important?

What is Benzene?

Partnered Content Networks

Relevant Topics